A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
Recap by typeshit. Full story at Futurism.
Harvard's Pieter Cohen and Johns Hopkins' Caleb Alexander advise against unapproved injectable peptides as HHS reportedly plans to let pharmacies compound some.
WebMD notes that eating less on a GLP-1 can mean missing some nutrients, and suggests asking your doctor about nutrition while on the drug.
The FDA notice says the pharmacy can't assure the vials are sterile. Check the full details to see which compounded products are affected.
Doctors describe a patient who developed a bowel obstruction after moving from tirzepatide to semaglutide unsupervised, following a long break in treatment.
A brief Facebook post says a daily pill might help people who worry about putting weight back on once they come off Wegovy. It names no drug or study.
8:09
Regan Archibald gives his take on the timeline for retatrutide reaching patients. Tap through for his view on where the drug stands.
Loading…